US2020319166A1PendingUtilityA1

Compositions and methods for detecting and treating pathological fibroblast cells

Assignee: UNIV DUKEPriority: Sep 27, 2018Filed: Jun 23, 2020Published: Oct 8, 2020
Est. expirySep 27, 2038(~12.2 yrs left)· nominal 20-yr term from priority
A61K 39/3955C07K 2317/73A61P 11/00G01N 33/5091G01N 2800/085C07K 16/2896C12Q 1/6881G01N 33/56966G01N 2800/10C12Q 1/6883C12Q 2600/158G01N 2333/705A61K 45/06G01N 2800/12
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compositions, kits and methods for assessing the presence of pathological fibroblasts within a biological sample are provided. In addition, compositions, kits and methods for detecting fibrosis are provided. Also provided are methods for treating fibrosis and conditions characterized with pathological fibroblasts.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of characterizing a sample, the method comprising:
 a) assaying for the presence of fibroblast cells expressing pro-N-cadherin in a sample obtained from a subject; and   b) characterizing the sample as i) having pathological fibroblast cells if the presence of fibroblast cells expressing pro-N-cadherin are detected in the assaying step, or ii) not having pathological fibroblast cells if the presence of fibroblast cells expressing pro-N-cadherin are not detected in the assaying step.

Join the waitlist — get patent alerts

Track US2020319166A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.